Account
iProspect India added three clients in 2017
MUMBAI: iProspect India, the digital agency from Dentsu Aegis Network won three new clients in the January to March 2017 quarter – BloombergQuint, HCL Technologies and IndiaProperty.
Digital news platform, BloombergQuint has assigned iProspect India for Paid Media services and will be serviced from Mumbai. Leading information technology company, HCL Technologies will be serviced from New Delhi and have partnered with iProspect India for Search Engine Optimization (SEO). One of the premier property websites in the country, IndiaProperty will be serviced from Bengaluru and is on board for the Search Engine Marketing (SEM) and Paid Media mandates.
iProspect India CEO Rubeena Singh said, “We are thrilled to have started the new year with multiple new clients. Each of these brands have entrusted us with specific digital marketing requirements and we are glad to join hands with them in achieving these goals. What’s encouraging is that they span across different sectors – we look forward to strategizing and executing innovative, creative and effective digital campaigns for them.”
iProspect India, a part of the Dentsu Aegis Network, is one of the country’s leading, multi award-winning digital agencies. DAN’s presence in India comprises global network brands Carat, Isobar, Posterscope, Vizeum, MKTG, Amnet and mcgarrybowen.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
